Abstract
The purpose of this study was to assess medication compliance and to document side effects among a large number of Japanese patients receiving antihypertensive treatment. A total of 6289 patients being treated for hypertension returned completed questionnaires about their current blood pressure, therapy, side effects, and compliance with physicians' instructions. In addition, 4417 physicians returned completed questionnaires about their prescribing practices, side effects experienced by patients, and patient compliance. The antihypertensive agents they most often prescribed were calcium channel blockers, followed by angiotensin-converting enzyme inhibitors, beta-blockers, and diuretics. The proportion of patients who had well-controlled blood pressure, defined as systolic blood pressure < 160 mm Hg and diastolic blood pressure < 95 mm Hg, was similar regardless of the class of antihypertensive agent prescribed. Forty-nine percent of the patients with well-controlled blood pressure reported having at least one side effect while taking their current antihypertensive therapy, whereas a significantly greater percentage of patients (61%) with poorly controlled blood pressure reported side effects. Patients whose blood pressure was p...Continue Reading
Citations
Dec 6, 2001·Current Hypertension Reports·R Düsing
Nov 4, 2000·Current Hypertension Reports·K A Payne, S Esmonde-White
Mar 31, 2006·Journal of Human Hypertension·S RagotD Herpin
Apr 25, 2007·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Benjamin A TollStephanie S O'Malley
Jun 6, 2002·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Ikuo SaitoHirotaka Shibata
Mar 25, 2008·Therapeutics and Clinical Risk Management·Nicola Fitz-SimonJohn Feely
Oct 2, 2008·Internal Medicine·Reiko MizunoShinobu Nakamura
Aug 24, 2013·Journal of the American Society of Hypertension : JASH·P S LedurB D Schaan
Sep 9, 2008·Journal of Clinical Epidemiology·Keiko WadaKoji Tamakoshi
Dec 9, 2015·American Journal of Hypertension·Yacob G Tedla, Leonelo E Bautista
Mar 26, 2004·Pharmacotherapy·Steven R EricksonLarry D Gruppen
Dec 19, 2013·Journal of Food Science·Ping ZouJianping Wu
Nov 22, 2001·American Heart Journal·W B WhiteH R Black
Nov 13, 2012·Journal of Ethnopharmacology·Weiyang TaoLing Yang
Mar 27, 2013·Archives of Cardiovascular Diseases·Jacques BlacherDominique Guedj-Meynier
Jan 21, 2010·Cadernos de saúde pública·Maria Ines Battistella NemesCáritas Relva Basso
Apr 28, 2017·Journal of Hypertension·Antonio CocaGiuseppe Mancia
May 3, 2006·Hypertension·Michael T HalpernNorman K Hollenberg
Apr 1, 2004·Expert Review of Pharmacoeconomics & Outcomes Research·Krista A Payne, J Jaime Caro
Aug 9, 2001·Journal of Human Hypertension·S R EricksonL D Gruppen
Aug 9, 2019·Evidence-based Complementary and Alternative Medicine : ECAM·Tian ShenRong Shi
Jan 8, 2016·Journal of Patient Safety·Slobodan M JankovicMarina Kostic
Oct 2, 2019·Frontiers in Aging Neuroscience·Jongjoo SunJ Mikhail Kellawan
Jul 31, 2003·Biological Research for Nursing·Bhagat K ReddyChristopher J Cooper
Jul 6, 2017·Critical Reviews in Food Science and Nutrition·Sania SaljoughianAmin Mousavi Khaneghah
Nov 14, 2013·Experimental and Therapeutic Medicine·Chun-Song ZhengXian-Xiang Liu
May 1, 2021·Genes·Sihle E MabhidaRabia Johnson